Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo

被引:1
|
作者
Fan, Rong [1 ]
Satilmis, Hatice [1 ]
Vandewalle, Niels [1 ]
De Bruyne, Elke [1 ]
Menu, Eline [1 ]
Chantry, Andrew D. [2 ]
Evans, Holly [2 ]
Torngren, Marie [3 ]
Eriksson, Helena [3 ]
Breckpot, Karine [4 ]
Maes, Ken [1 ]
Vanderkerken, Karin [1 ]
De Veirman, Kim [1 ]
机构
[1] Vrije Univ Brussel, Myeloma Ctr Brussels, Dept Hematol & Immunol, Brussels, Belgium
[2] Univ Sheffield, Sch Med, Dept Oncol & Metab, Sheffield, England
[3] Act Biotech AB, Lund, Sweden
[4] Vrije Univ Brussel, Lab Mol & Cellular Therapy, Brussels, Belgium
关键词
D O I
10.1182/blood-2021-147744
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1594
引用
收藏
页数:4
相关论文
共 1 条
  • [1] Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
    Fan, Rong
    Satilmis, Hatice
    Vandewalle, Niels
    Verheye, Emma
    Vlummens, Philip
    Maes, Anke
    Muylaert, Catharina
    De Bruyne, Elke
    Menu, Eline
    Evans, Holly
    Chantry, Andrew
    De Beule, Nathan
    Hose, Dirk
    Toerngren, Marie
    Eriksson, Helena
    Vanderkerken, Karin
    Maes, Ken
    Breckpot, Karine
    De Veirman, Kim
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (01)